ArticleCriminology : an interdisciplinary journal2022
Collective efficacy and the built environment.
Article in Criminology : an interdisciplinary journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- The Protective Role of Collective Efficacy Against Illicit Drug Availability at the Street Level: A Longitudinal Analysis.Journal of urban health : bulletin of the New York Academy of Medicine · 2026Article
- Effective and Enduring Place-Based Interventions Against Firearm Violence and Serious Crime Require Mechanism-Based Analytical Thinking.American journal of public health · 2026Article
- Mobility Network-based Measurement of Local Collective Efficacy and its Consequences for the Spatial Patterning of Violent Crime.Journal of quantitative criminology · 2026Article
- Investment and crime on residential street segments: Assessing the moderating role of neighborhood characteristics.Cities (London, England) · 2025Article
- The Relationship between the Outdoor School Violence Distribution and the Outdoor Campus Environment: An Empirical Study from China.International journal of environmental research and public health · 2022Article
- Collective efficacy and the built environment.Criminology : an interdisciplinary journal · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
Collective efficacy is a prominent explanation for neighborhood crime concentrations. Just as crime is concentrated in particular neighborhoods, within-neighborhoods crime is concentrated in particular criminogenic locations. Research suggests criminogenic locations are determined by features of the built environment. This study links collective efficacy with situational opportunity to propose that collective efficacy facilitates the removal of criminogenic features of the built environment. I test this by examining associations 1) between past collective efficacy and present criminogenic features of the built environment, as well as 2) between those built environment features and crime, net of present collective efficacy. These are modeled using piecewise structural equations with generalized linear mixed-effect regressions on data from 1,641 blocks in 343 Chicago neighborhoods. Four types of police-reported crime are modeled using eight block-level built environment features in the 2003 Chicago Community Area Health Study (CCAHS; N = 3,074) and neighborhood collective efficacy from the CCAHS and the 1995 Project in Human Development in Chicago Neighborhoods (PHDCN) Community Survey (N = 7,672). Findings suggest neighborhoods with high collective efficacy maintain low rates of crime in part by limiting criminogenic built environment features, in particular, abandoned buildings. This crime control pathway is important because changes to the built environment are long lasting and reduce the need for future interventions against crime.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.